NO923004L - 6-oxo-azepinoindolforbindelser, saavel som fremgangsmaater og mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser - Google Patents

6-oxo-azepinoindolforbindelser, saavel som fremgangsmaater og mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser

Info

Publication number: NO923004L
Authority: NO; Norway
Prior art keywords: lower alkyl; compounds; cycloalkyl; alkyl group; optionally substituted
Prior art date: 1991-07-31

Application number

NO92923004A

Other languages

English (en)

Other versions

NO300375B1 (no

NO923004D0 (no

Inventor

Werner Benson

Karin Van Charldorp

Peter Colin Gregory

Klaus-Ullrich Wolf

Ulf Preuschoff

Martin Tulp

Ton Hulkenberg

Ineke Van Wijngaarden

Original Assignee

Kali Chemie Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-31

Filing date

1992-07-30

Publication date

1993-02-01

1992-07-30 Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh

1992-07-30 Publication of NO923004D0 publication Critical patent/NO923004D0/no

1993-02-01 Publication of NO923004L publication Critical patent/NO923004L/no

1997-05-20 Publication of NO300375B1 publication Critical patent/NO300375B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Indole Compounds (AREA)

NO923004A 1991-07-31 1992-07-30 6-okso-azepinoindolforbindelser, mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser NO300375B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4125292A DE4125292A1 (de)	1991-07-31	1991-07-31	6-oxo-azepinoindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (3)

Publication Number	Publication Date
NO923004D0 NO923004D0 (no)	1992-07-30
NO923004L true NO923004L (no)	1993-02-01
NO300375B1 NO300375B1 (no)	1997-05-20

Family

ID=6437366

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO923004A NO300375B1 (no)	1991-07-31	1992-07-30	6-okso-azepinoindolforbindelser, mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser

Country Status (21)

Country	Link
US (1)	US5272143A (no)
EP (1)	EP0525584B1 (no)
JP (1)	JP3174158B2 (no)
KR (1)	KR930002353A (no)
CN (2)	CN1069733A (no)
AT (1)	ATE161012T1 (no)
AU (1)	AU649153B2 (no)
CA (1)	CA2075102A1 (no)
CZ (1)	CZ239392A3 (no)
DE (2)	DE4125292A1 (no)
ES (1)	ES2110454T3 (no)
FI (1)	FI923440A7 (no)
HU (2)	HU211105B (no)
IE (1)	IE922310A1 (no)
IL (1)	IL102503A (no)
MX (1)	MX9204457A (no)
NO (1)	NO300375B1 (no)
NZ (1)	NZ243715A (no)
RU (1)	RU2078765C1 (no)
TW (1)	TW207541B (no)
ZA (1)	ZA925093B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5414130A (en) *	1993-12-23	1995-05-09	The Dow Chemical Company	Process for the preparation of diaminoresorcinol
EP1140936B1 (en)	1999-01-11	2004-03-17	Agouron Pharmaceuticals, Inc.	Tricyclic inhibitors of poly(adp-ribose) polymerases
ECSP003637A (es)	1999-08-31	2002-03-25	Agouron Pharma	Inhibidores triciclicos de poli (adp-ribosa) polimerasas
JP2008513435A (ja) *	2004-09-22	2008-05-01	ファイザー・インク	ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤を含む治療用組成物
CA2580833C (en) *	2004-09-22	2010-12-21	Pfizer, Inc.	Method of preparing poly(adp-ribose) polymerases inhibitors
KR101653707B1 (ko) *	2008-05-29	2016-09-02	알바니 몰레큘라 리써치, 인크.	5-ｈｔ3 수용체 조절제, 이의 제조 방법, 및 그의 용도
ES2607806T5 (es) *	2010-02-12	2024-10-07	Pfizer	Sales y polimorfos de 8-fluoro-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6H-azepino[5,4,3-cd]indol-6-ona
US10513515B2 (en)	2017-08-25	2019-12-24	Biotheryx, Inc.	Ether compounds and uses thereof
WO2020023782A1 (en)	2018-07-27	2020-01-30	Biotheryx, Inc.	Bifunctional compounds as cdk modulators
EP4143329A4 (en)	2020-04-28	2024-10-16	Anwita Biosciences, Inc.	Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4910193A (en) *	1985-12-16	1990-03-20	Sandoz Ltd.	Treatment of gastrointestinal disorders

1991
- 1991-07-31 DE DE4125292A patent/DE4125292A1/de not_active Withdrawn
1992
- 1992-07-08 ZA ZA925093A patent/ZA925093B/xx unknown
- 1992-07-15 IL IL10250392A patent/IL102503A/en not_active IP Right Cessation
- 1992-07-15 IE IE231092A patent/IE922310A1/en not_active Application Discontinuation
- 1992-07-21 AT AT92112431T patent/ATE161012T1/de not_active IP Right Cessation
- 1992-07-21 EP EP92112431A patent/EP0525584B1/de not_active Expired - Lifetime
- 1992-07-21 ES ES92112431T patent/ES2110454T3/es not_active Expired - Lifetime
- 1992-07-21 DE DE59209055T patent/DE59209055D1/de not_active Expired - Fee Related
- 1992-07-24 NZ NZ243715A patent/NZ243715A/en unknown
- 1992-07-24 HU HU9202430A patent/HU211105B/hu not_active IP Right Cessation
- 1992-07-30 NO NO923004A patent/NO300375B1/no unknown
- 1992-07-30 AU AU20677/92A patent/AU649153B2/en not_active Ceased
- 1992-07-30 FI FI923440A patent/FI923440A7/fi not_active Application Discontinuation
- 1992-07-30 MX MX9204457A patent/MX9204457A/es not_active IP Right Cessation
- 1992-07-30 KR KR1019920013719A patent/KR930002353A/ko not_active Withdrawn
- 1992-07-30 RU SU925052604A patent/RU2078765C1/ru active
- 1992-07-30 JP JP20377092A patent/JP3174158B2/ja not_active Expired - Fee Related
- 1992-07-30 CN CN92108977A patent/CN1069733A/zh active Pending
- 1992-07-31 US US07/922,527 patent/US5272143A/en not_active Expired - Lifetime
- 1992-07-31 CA CA002075102A patent/CA2075102A1/en not_active Abandoned
- 1992-07-31 CZ CS922393A patent/CZ239392A3/cs unknown
- 1992-09-10 TW TW081107187A patent/TW207541B/zh active
1994
- 1994-09-30 HU HU94P/P00032P patent/HU210217A9/hu unknown
1996
- 1996-01-19 CN CN96100699A patent/CN1141773A/zh active Pending

Also Published As

Publication number	Publication date
JPH05202052A (ja)	1993-08-10
HUT65453A (en)	1994-06-28
KR930002353A (ko)	1993-02-23
DE59209055D1 (de)	1998-01-22
EP0525584B1 (de)	1997-12-10
NO300375B1 (no)	1997-05-20
HU211105B (en)	1995-10-30
US5272143A (en)	1993-12-21
CN1069733A (zh)	1993-03-10
JP3174158B2 (ja)	2001-06-11
RU2078765C1 (ru)	1997-05-10
NZ243715A (en)	1995-03-28
HU9202430D0 (en)	1992-10-28
HU210217A9 (en)	1995-02-28
CA2075102A1 (en)	1993-02-01
ZA925093B (en)	1993-04-28
CN1141773A (zh)	1997-02-05
MX9204457A (es)	1993-05-01
IL102503A (en)	1995-12-31
AU649153B2 (en)	1994-05-12
DE4125292A1 (de)	1993-02-04
EP0525584A1 (de)	1993-02-03
AU2067792A (en)	1993-02-04
IL102503A0 (en)	1993-01-14
IE922310A1 (en)	1993-02-10
ATE161012T1 (de)	1997-12-15
FI923440A7 (fi)	1993-02-01
FI923440A0 (fi)	1992-07-30
ES2110454T3 (es)	1998-02-16
TW207541B (no)	1993-06-11
NO923004D0 (no)	1992-07-30
CZ239392A3 (en)	1993-04-14

Publication	Publication Date	Title
NO924929L (no)	1992-12-18	Farmasoeytisk aktive benzoquinazolinforbindelser
PL263885A1 (en)	1988-09-15	Method of obtaining novel derivatives of dihydrobenzofurane and chromate carbonamide
NO911158L (no)	1991-09-25	Hydantoinderivater.
ES8401961A1 (es)	1984-01-01	Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
NO923004D0 (no)	1992-07-30	6-oxo-azepinoindolforbindelser, saavel som fremgangsmaater og mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser
ES8607218A1 (es)	1986-05-16	Un procedimiento para preparar compuestos de amidina
ZA816259B (en)	1983-04-27	2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
DZ1482A1 (fr)	2004-09-13	Hemi-hydrate.
ATE92470T1 (de)	1993-08-15	Carboxyalkyl-ether von 2-amino-7-hydroxytetralin.
ATE46511T1 (de)	1989-10-15	Neue 8-alkylthio-2-piperazino-pyrimido(5,4d>pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel.
NO871575L (no)	1987-10-16	Fremgangsmaate for fremstilling av 1,5-benztiazepin-derivater.
ATE83482T1 (de)	1993-01-15	Piperidin-derivate, deren herstellung und deren verwendung als heilmittel.
AU658175B2 (en)	1995-04-06	Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
ATE70838T1 (de)	1992-01-15	Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
NO855383L (no)	1986-07-14	Fremgangsmaate for fremstilling av piperazin-derivater.
ATE147268T1 (de)	1997-01-15	Hypoglycemische peptide
ATE110367T1 (de)	1994-09-15	Kalziumantagonisten.
AU4370489A (en)	1990-05-03	The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents
SE8802162D0 (sv)	1988-06-09	Nya aminoacylater av glycerolacetal